Introduction. Pregnancy after frozen-thawed embryo transfer (FET) is a multifactorial process. Although embryo quality is a key factor in determining pregnancy, other factors, including maternal determinants, are also considered to be predictive. Even though an association between endometrial thickness measured by transvaginal ultrasound and pregnancy rates has been reported in patients undergoing various assisted reproductive technology treatments, whether endometrial thickness predicts achieving pregnancy after natural cycle FET (NC-FET) remains unclear. Material and methods. In this cohort study, 463 patients allocated to the modified NC-FET (mNC-FET) arm of a previously published randomized controlled trial were included. Monitoring in mNC-FET cycles consisted of regular ultrasound scans, measuring both dominant follicle and endometrial thickness. When the dominant follicle reached a size of 16-20 mm, an injection of human chorionic gonadotrophin was administered and embryo thawing and transfer planned. No minimal endometrial thickness was defined below which transfer was to be deferred. The primary endpoint was ongoing pregnancy rate. Results. Overall, the ongoing pregnancy rate per started FET cycle was 12.5%. Multivariate regression analyses showed that embryo quality was the only significant predictor for ongoing pregnancy. Mean endometrial thickness did not differ between patients achieving ongoing pregnancy and those who did not (9.0 vs. 8.8 mm, p = 0.4). Comparable results were obtained with regard to clinical pregnancy, live birth and miscarriage rates. The area under the receiver operator curve was 0.5, indicating little discriminatory value of endometrial
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Introduction
Although achieving pregnancy after frozen-thawed embryo transfer depends on a multitude of factors, it is generally agreed that the key elements influencing live birth rates are the quality and number of embryos transferred (1). Even though embryo-related factors are considered to be the most important, endometrial thickness is often routinely monitored and embryo transfer sometimes avoided if endometrial thickness is considered too thin. Although most information on the effect of endometrial thickness is derived from stimulated cycles (both in vitro fertilization (IVF) and artificial cycle frozen embryo transfer [AC-FET)], the effect of endometrial thickness on clinical and ongoing pregnancy or live birth rate in natural cycle frozen-thawed transfer cycles (NC-FET) has not been extensively studied.
For the human endometrium to become receptive to the embryo, a shift from proliferative state to secretory state endometrium has to take place. This transition is predominantly orchestrated by the peri-ovulatory rise in progesterone. Exposure of the endometrium to progesterone results in an arrest in proliferation and maturation of the endometrium (2, 3) .
The increase in endometrial thickness and the appearance of a hypo-echogenic trilaminar aspect as a result of the proliferation of the endometrium in response to estradiol exposure, can be visualized in a simple and noninvasive way using ultrasound (4). After ovulation, under the influence of progesterone, the appearance of the endometrium changes, becoming more compact and hyper-echogenic. Ultrasonic evaluation of the endometrium might therefore help in determining whether the endometrium has been adequately developed and has reached a state of optimal receptivity.
Various ultrasonic parameters have been suggested, but the most commonly used parameter to confirm endometrial receptivity is endometrial thickness. A recent survey showed that in over 75% of frozen embryo transfer (FET) programs, endometrial thickness is routinely measured (5).
Key message
After modified natural cycle frozen-thawed transfer, embryo quality is the key outcome predictor for ongoing pregnancy. Endometrial thickness does not predict ongoing pregnancy rates after modified natural cycle frozen-thawed transfer and therefore cancellation based solely on endometrial thickness may not be justified.
Even though the predictive value of endometrial thickness in NC-FET has not yet been extensively evaluated, a minimum of 7 mm is widely applied in FET programs to proceed with thawing and transferring. Current practice is therefore based on the interpretation of studies of the predictive value of endometrial thickness for achieving pregnancy in patients undergoing ovarian stimulation or taking exogenous hormone supplementation in preparation for FET. However, these studies have shown conflicting results and none controlled for any known confounding factors such as age or ethnicity (6) (7) (8) (9) (10) . Since proliferation of the endometrium is governed by estrogens, which are generated in supraphysiological concentrations during ovarian stimulation, the results of these studies cannot be applied to spontaneous conceptions or patients undergoing NC-FET. In NC-FET, endocrine control of the cycle is obviously not altered and endometrial development depends on endogenous estrogen and progesterone alone.
If endometrium thickness in NC-FET does influence pregnancy rates, it would be helpful to identify a minimal endometrium thickness below which clinical pregnancy rates are decreased. Cancellation of treatment cycles in which the endometrial thickness falls below this cut-off value, and altering the endometrial preparation regimen might improve outcomes. In this cohort study, the predictive value of late follicular phase endometrial thickness for achieving pregnancy after mNC-FET was investigated. Moreover, we sought to establish whether there is a minimal endometrium thickness below which cancellation of treatment should be considered.
Material and methods

Patients and procedures
All subjects were participants in a previously published multicenter randomized controlled trial (RCT) (trial registration; Netherlands trial register, number 1586) (11, 12) . An extensive description of the inclusion and exclusion criteria can be found in the previous publication on the ANT-ARCTICA trial (11, 12) . In summary, patients included were between 18 and 40 years old and the frozen-thawed embryos transferred derived from one of the first three conventional IVF or IVF-intracytoplasmic sperm injection (ICSI) treatments. Subjects had regular menstrual cycles. Patients with a contraindication for one of the prescribed medicines in AC-FET, a uterine anomaly or who were undergoing IVF for the purpose of gamete donation were excluded. Previous intrauterine surgery was not an exclusion criterion. All patients were enrolled for one cycle of endometrial preparation irrespective of whether thawing led to embryo transfer. Those patients randomized to mNC-FET were included in the present study.
From cycle days 10 to 12 all patients underwent daily or every other day ultrasound examination of the follicle size and endometrial thickness. Ultrasound was performed using a vaginal ultrasound with a 2D 5-MHz probe. The endometrial thickness was measured in the longitudinal plane placing the calipers on the outer lining of the endometrium. When a dominant follicle of 16-20 mm was found, a single human chorionic gonadotropin (hCG) injection (5000 IU Pregnyl â or 250 lm Ovitrelle â , Merck, Kenilworth, NJ, USA) was administered the same day. Measurements of the endometrium were carried out until the day of hCG injection. No additional endocrine monitoring was performed and no luteal phase support was prescribed. No cancellation criteria relating to the endometrial thickness were described in the study protocol but if the dominant follicle was no longer visible during ultrasound, treatment was cancelled based on a suspicion of ovulation in order to avoid incorrect timing of thawing and transferring. Planning of thawing and transfer were based on the day of hCG injection and the developmental stage of the embryo. To ensure an interval of at least 36 h between hCG injection and embryo transfer, the hCG injection was administered during evening hours (13) . In the fresh cycle, if the day of ovum pick-up is regarded as day 0, the embryos were frozen on day 3, 4 or 5. In the mNC-FET cycle, regarding the day of hCG injection as day 0, the embryos were thawed on day 4, 5 or 6, respectively. Embryo transfer was performed on the day of thawing or the subsequent day. All embryos were cryopreserved using a slow-freeze technique. Embryos were scored and selected after thawing based on morphological features. All participating centers used a uniform scoring system based on the Istanbul consensus. Number and symmetry of cells, degree of fragmentation as well as continuous development after thawing were taken into account when scoring the embryos. Embryos were given a summary score describing them as good, reasonable, moderate or poor quality (14) . A maximum of three embryos per transfer was permitted within the study design.
Statistical analyses
Given that the cohort studied in the present study derived from an RCT designed for another purpose, a formal sample size calculation prior to the analysis could not be performed. SPSS (IBM Corp., Armonk, NY, USA) was used to perform statistical analysis. The primary endpoint in this study was ongoing pregnancy, defined as an intrauterine pregnancy with fetal cardiac activity from 12 weeks of pregnancy of gestation detected on ultrasound. Secondary endpoints included clinical pregnancy rate (CPR), live birth rate (LBR) and miscarriage rate (MR). Analysis were performed according to the principle of intention-to-treat (outcome per started treatment) and per protocol (outcome per embryo transfer).
Baseline characteristics were compared between pregnant patients and non-pregnant patients with the help of a Student t-test, Mann-Whitney U-test or Chi-square test depending on the distribution and type of the data. To identify possible predictors for ongoing pregnancy, univariate regression analyses were initially performed. Those factors with a p-level ≤0.2 in the univariate logistic regression analysis were incorporated into a subsequent multivariate logistic regression analysis that also included potential confounding factors affecting the chance of achieving ongoing pregnancy. A confounding factor was considered significant if a p-level <0.05 was reached.
Secondarily, to study the role of endometrial thickness in more detail, we further focused on the relation between endometrial thickness and ongoing pregnancy rates. The distribution of the endometrial measurements was visualized by the drawing of box-whisker plots. To assess whether an endometrium thickness at one extreme of the spectrum influences pregnancy and/or live birth rates, pregnancy and live birth rates per quartile were calculated and compared using a Chi-square test. To determine the predictive value of endometrial thickness for clinical pregnancy, and to identify a thickness below which CPRs were significantly reduced, a receiver operator curve (ROC) was constructed. A Student t-test was performed to test for significant differences in average endometrium thickness in patients who became pregnant vs. those who did not. A subgroup analysis using a Chi-square test or Fisher Exact test, depending on the distribution of cases in the cross-table, was performed including calculation of odds ratio (OR) and 95% confidence intervals (CI) to estimate the effect of a thin endometrium (<7 mm) (5, 6) .
Ethical approval
The RCT in which the patients were analyzed in the current paper was approved by the Medical Ethical Board of the Isala in Zwolle. Approval for conduct of the trial was received on 10 March 2009.
Results
Between February 2009 and April 2014, 969 patients were included in the RCT, of which 495 were randomized to undergo mNC-FET. No endometrium thickness was recorded in 32 patients and these patients were therefore considered lost to follow up, leaving 463 patients for analysis. Treatment was cancelled in 85 patients. In three patients, protocol violations occurred as treatment was cancelled based on endometrial thickness. The flowchart in Figure 1 summarizes the distribution of patients and summarizes reasons for cancellation. The average female age at the time of randomization was 33.3 years and the average duration of infertility was 2.9 years. Most patients included underwent IVF-ICSI treatment [264 (53.3%) IVF-ICSI vs. 231 (46.7%) conventional IVF] and in 78 patients (15.8%) the fresh IVF-ICSI treatment resulted in a live birth. Subjects included in the present study had undergone a mean of 0.65 IVF treatment cycles prior to the IVF treatment from which the frozen-thawed embryos transferred originated. The clinical indications for treatment in the majority of patients were severe male factor (216/463, 40.8%) followed by unexplained subfertility (113/463, 21.3%) and tubal occlusion (79/463, 14.9%). More detailed information on baseline characteristics of the study cohort have been published previously (12) . In the majority of the cases, a single embryo transfer was performed (82.4%). A double embryo transfer was performed in 17.4% patients. One patient (0.2%) underwent a triple embryo transfer. In 85 patients (18.4%) treatment was cancelled before an embryo transfer could be executed. Study subjects received a mean of 1.0 embryos during transfer. In the majority of patients, embryo transfer was performed the day after thawing (55.6%). The mean survival rate was 75%. The average embryo score was "reasonable to good". The decision whether to transfer was made by the treating clinic, as no low embryo quality cut-off was obtained in the study protocol. No information on whether patients had a history of intrauterine surgery was available.
Ongoing pregnancy rate (OPR) per started FET cycle was 12.5% (58/463) and CPR and LBR were respectively 19.6% (91/463) and 12.1% (56/463) per started cycle (Table 1) . Results per embryo transfer were respectively 15.3% (58/378), 24.1% (91/378) and 14.8% (56/378). Endometrial thickness did not differ significantly between patients who achieved an ongoing pregnancy and those that did not (9.0 vs. 8.8 mm, p = 0.4). Similarly, no significant differences in mean endometrial thickness were observed for clinical pregnancy, live birth or miscarriage (Table 1 ). Despite the observation that endometrial thickness was not significantly different between patients achieving pregnancy and those who did not, the impact of endometrial thickness was further explored given that perhaps the cut-off value of <7 mm for the definition "thin endometrium" might not be just. The box-whisker plots in Figure 2 provide information on the distribution of endometrial thickness among the various outcomes. Outcomes per quartile are summarized in Table 2 . Figure 3 displays the ROC curve constructed from the data available. The area under the curve was 0.5 (p = 0.5), confirming the results of the multivariate analyses. Moreover, no cut-off value of endometrial thickness below which pregnancy did not occur could be identified.
Various predictors for pregnancy and live birth after FET have been described. To address these predictive factors, both a univariate and multivariate logistic regression analysis were performed. Those parameters with a p-value of ≤0.20 were included in the multivariate analysis. The multivariate analysis was performed using a stepwise enter method. Included nonsignificant variables were age at the moment of randomization (OR 1.0, 95% CI 0.9-1.1), duration of cryopreservation (OR 0.8, 95% CI 0.7-1.6), total number of IVF treatment including the index treatment (OR 1.1, 95% CI 0.7-1.5), pregnancy after fresh embryo transfer in the index treatment (OR 1.1, 95% CI 0.5-2.4), total number of prior FET (OR 1.0, 95% CI 0.8-1.4), number of embryos transferred (OR 1.4, 95% CI 0.7-2.7), stage at the moment of cryopreservation (OR 1.4, 95% CI 0.5-3.7), embryo survival (OR 0.9, 95% CI 0.8-1.0) and whether or not overnight embryo culture was performed (OR 1.2, 95% CI 0.8-1.6). Average embryo quality was the only significant predictive factor (OR 2.0, 95% CI 1.4-3.0, p < 0.01). The impact of an endometrial thickness <7 mm for achieving an ongoing pregnancy remained nonsignificant even after correcting for age (OR 1.0, 95% CI 0.8-1.1) ( Table 3 ). The intention-to-treat analyses did not alter the results significantly.
Discussion
The present study assesses the effect of endometrial thickness on pregnancy rates in mNC-FET. In this prospective cohort study, no statistically significant relation between endometrium thickness, CPR, OPR, LBR and miscarriage rate in patients undergoing mNC-FET could be established. No minimal endometrium thickness for proceeding with treatment without compromising pregnancy rates could be identified. However, caution is warranted given the relatively small sample size.
In the context of stimulated cycles, two large retrospective studies report a significantly lower CPR in patients with an endometrium thickness of less than 8-9 mm, respectively (8, 9) . In another study of patients undergoing AC-FET, pregnancy rates were shown not to be influenced by endometrial thickness (7) . However, since a minimal endometrium of ≥9 mm was required by Check et al. (7) Figure 1 . Flowchart of patients. hCG, human chorionic gonadotropin; mNC-FET, modified natural cycle frozen-thawed transfer; RCT, randomized controlled trial. for embryo thawing and transfer to proceed, the impact of a thin endometrium was not assessed. A recent meta-analysis of studies in IVF cycles concluded that endometrium thickness has a limited capacity for predicting pregnancy rates (6) . The authors did report lower pregnancy rates in women with an endometrium thickness of <7 mm but this was a relatively rare event, being observed in only 2.4% of the patients. In the present study, an endometrial thickness <7 mm was observed in 8.9% of the patients. This difference in incidence might reflect the use of ovarian stimulation in the reviewed studies. Despite the observed trend towards lower pregnancy rates in woman with an endometrial thickness <7 mm, caution is necessary because the number of patients in the subgroup analyses was limited. A small retrospective study containing 62 patients undergoing true NC-FET showed a comparable negative effect of an endometrial thickness <7 mm (15) . So, even while an endometrial thickness of 7 mm is considered by many to be the minimal endometrial thickness required before proceeding to thawing and transferring, a robust foundation for this assumption is missing (5). Therefore, larger cohort studies are needed. Aside from the impact on the probability of achieving a pregnancy, some suggest that endometrial thickness may be a factor that also influences risk of pregnancy complications (16, 17) . However, data on this subject remain sparse. Consistent with previous reports, embryo quality was confirmed in the present study to be the key independent predictor for ongoing pregnancy. Veleva et al. showed that transfer of a high quality embryo resulted in higher pregnancy and live birth rates, and comparable results were obtained by others (1, 15, 16) . However, none of these studies included endometrial thickness in their analyses. Given the strong predictive value of embryo quality, it is widely held that the embryo is more decisive determinant of implantation compared with the endometrium. However, recent studies focussing on the role of the endometrium during implantation have challenged this paradigm (17) . Endometrial thickness seems to reflect the histological, immunological as well as gene-expression features related to optimal receptivity (18, 19) . The lack of predictive value of endometrial thickness might therefore not be a true lack of predictive value of the endometrium but merely an inappropriate method of measuring (20) . The question therefore remains whether a thin endometrium represents a pathophysiological process. Various suggestions as to the cause of a thin endometrium in the absence of Ashermans' syndrome have been put forward. An impaired development of the glandular epithelium as well as poor angiogenesis have been implicated by some (21) . Reduced blood flow due to an increased vascular impedance of uterine and radial arteries also has been reported in patients with a thin endometrium (22, 23) . However, given the lack of convincing rationale for how endometrial thickness might determine pregnancy and live birth rates, more data are required if insufficient endometrial thickness is to be considered a valid criterion for canceling FET cycles. A number of limitations of this study need to be considered when interpreting the findings. The studied cohort was derived from an RCT designed for another purpose. A formal sample size calculation therefore could not be performed and a substantial larger sample would have been required to ensure robust statistical power. CPR, OPR and LBR seem to be relatively low compared with other studies, making the result of this study less valid. The number of transferred embryos, the percentage of cleavage stage embryos and the reasonable embryo quality might be the cause of this discrepancy. However, it cannot be excluded that any impact of endometrial thickness was partially masked by the overall low pregnancy rates observed. The conclusions in relation to live birth and miscarriage should be interpreted with some caution due to the number of patients included in this analysis. Moreover, regretfully, no information was available on previous intrauterine surgery. All embryos were cryopreserved using a slow-freeze procedure. Given that implantation rates are not influenced by the method of cryopreservation and the results of the present study mirror the outcomes of previous studies on endometrial thickness in patients undergoing ovarian stimulation, the results can regarded as valid (18, 19) .
Despite these caveats, the study has a number of important strengths. Since no minimal censoring endometrium thickness was defined in the original study protocol, the effect of the whole spectrum of endometrial thicknesses in mNC-FET could be studied. In three patients, protocol violation led to embryo transfer being withheld because of endometrial thickness, but this low number is unlikely to have an impact on the study findings. The lack of censoring with regard to endometrial thickness combined with the number of patients included allowed robust conclusions to be made with regard to the impact on clinical and ongoing pregnancy. Considering that both secondary and tertiary clinics participated in this study and that commonly applied 2D ultrasound was used, the study findings are applicable to daily practice. Interobserver agreement of endometrium thickness measurement is excellent and we therefore consider, despite the large number of physicians involved, the risk and influence of interobserver variation marginal (20) (21) (22) .
In conclusion, based on the results of the present study, thawing and transferring in mNC-FET can be planned irrespective of endometrial thickness. In patients with an endometrial thickness of <7 mm, pregnancy rates seems to be lower. Both conclusions should be confirmed in a larger cohort study. Until then, the present data indicated that canceling cycles solely on the basis of endometrial thickness may not be indicated in mNC-FET.
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